<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03015857</url>
  </required_header>
  <id_info>
    <org_study_id>cesarean sections</org_study_id>
    <nct_id>NCT03015857</nct_id>
  </id_info>
  <brief_title>Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension</brief_title>
  <official_title>A Comparison Between Phenylephrine and Norepinephrine Boluses in Prevention of Post-spinal Hypotension During Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypotension following spinal anesthesia for cesarean section is a serious problem. In this
      study we investigated the effect of the vasopressors phenylephrine and noradrenaline on
      postspinal hypotension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On arrival to the operating room, an 18g cannula will be inserted and monitors will be
      applied (electrocardiography - pulse oximetry - non-invasive blood pressure monitor).
      Patients will receive spinal anesthesia with 500 ml rapid crystalloid co-load. Ten milligrams
      heavy bupivacaine in addition to 20 mcg fentanyl will be injected in L3-L4 or L4-L5
      interspace using 25 g spinal needle in the sitting position.

      After spinal block, patients will be randomly allocated into one of two groups:

        -  Phenylephrine group (n=100)

        -  Norepinephrine group (n=100)

      Patients who shows SBP above 140 mmHg or heart rate below 55 bpm after the first vasopressor
      dose will not receive the infusion. The infusion will stop if the SBP was above 140 mmHg or
      if the heart rate was below 55 bpm. Patients will be positioned in the supine position with
      left lateral tilt. Block success will be assessed using pinprick, patients with failed block
      will be excluded from the study. The highest sensory block level will be assessed after 5
      minutes from intrathecal injection. Co-hydration will be continued till maximum of 1.5
      litres.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of post spinal hypotension (PSH) defined as percentage of patients with decreased systolic blood pressure less than 80% of the baseline reading during the period from intrathecal injection to delivery of the fetus)</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>systolic and diastolic blood pressures measured in mm Hg</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate measured in beats per minute</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea and vomiting measured in number of attacks</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Adverse Anesthesia Outcome</condition>
  <arm_group>
    <arm_group_label>phenylephrine,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>- Phenylephrine group (n=100): will receive 100 mcg phenylephrine as a single bolus just after intrathecal injection of 10 mg bupivacaine plus 20 mcg fentanyl. The dose will be diluted in 5 mL and given over seconds. A continuous infusion with placebo (normal saline) will start after the first bolus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>norepinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>- Norepinephrine group (n=100): will receive bolus of norepinephrine (10 mcg) directly after spinal block using 10 mg bupivacaine plus 20 mcg fentantanyl followed by continuous infusion of norepinephrine with a rate of 0.1 mcg/kg/min till delivery of the fetus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>phenylephrine</intervention_name>
    <description>- phenylephrine; a vasopressor drug given to prevent post spinal hypotension</description>
    <arm_group_label>phenylephrine,</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>- norepinephrine; a vasopressor drug given to prevent post spinal hypotension</description>
    <arm_group_label>norepinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>intrathecal bupivacaine 10 mg will be given in both groups</description>
    <arm_group_label>phenylephrine,</arm_group_label>
    <arm_group_label>norepinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>intrathecal fentanyl 20 mcg will be given in both groups</description>
    <arm_group_label>phenylephrine,</arm_group_label>
    <arm_group_label>norepinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (normal saline)</intervention_name>
    <arm_group_label>phenylephrine,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  full term singleton parturients

          -  elective cesarean sections

        Exclusion Criteria:

          -  cardiac morbidities

          -  hypertensive disorders of pregnancy

          -  peripartum bleeding

          -  body mass index &gt; 35 will be excluded from the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shereen Refaat, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Lecturer of anesthesia Faculty of medicine Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tamer M Rook, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Lecturer of anesthesia Faculty of medicine Cairo university</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2016</study_first_submitted>
  <study_first_submitted_qc>January 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2017</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>ahmed elsakka</investigator_full_name>
    <investigator_title>Principal investigator and lecturer of anesthesia, faculty of medicine cairo university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

